Shares of Nasdaq-listed Helius Medical Technologies (HSDT) soared nearly 15% after the company announced a new financing program related to Solana, in which it owns a stake ($SOL).
The company will now allow financial institutions to borrow according to the amount invested. $SOL without selling or unstaking. The move sparked investor interest, especially after the stock hit a record low earlier this week.
How the financing program works
HSDT launched the program in partnership with Anchorage Digital and Kamino Finance.
Educational institutions are $SOL Continue to bet, earn rewards, and borrow more funds. Assets remain in custody while the company accesses liquidity. Companies do not need to sell tokens to raise cash.
This setup helps financial institutions manage their cash needs while holding long-term crypto investments.
why is it important now
Solana’s price fell from a high of around $245 to around $83 during a broad market correction. This decline hit companies with large amounts of cash. $SOL spare.
HSDT remains well below its level prior to the transition to the Solana financial strategy. The recent stock price rally reflects optimism about improved capital management rather than a complete recovery in crypto prices.
Market impact
some $SOL– Focused companies are adjusting their approach. Some people are increasing their staking operations to get stable rewards. Some are looking for additional income strategies.
The broader crypto market continues to face pressure. However, companies continue to build financial tools around staking and lending. Investors responded positively to signs that financial institutions were improving risk management rather than exiting the sector.
For now, the stock price rally signals cautious confidence as companies look for ways to shore up their positions in volatile markets.
